Caricamento...
A New Mechanism of Action in Heart Failure: Angiotensin-Receptor Neprilysin Inhibition
Objective: To evaluate the efficacy, safety, and clinical significance of sacubitril/valsartan (Entresto) in patients with heart failure with a reduced ejection fraction (HFrEF). Data Sources: An extensive search was conducted on Ovid MEDLINE using keywords and medical subject headings LCZ696, sacub...
Salvato in:
| Pubblicato in: | J Pharm Technol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5998462/ https://ncbi.nlm.nih.gov/pubmed/34860952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122515622224 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|